Nephrolithiasis: Clinical Trials

4 trials for Nephrolithiasis, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

4 terminated. 4 Phase 2, 1 Phase 1, 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 24Terminated 4
Phase 11Terminated 1
Phase 31Terminated 1

Follow Nephrolithiasis: new trials by email Literature Review of Nephrolithiasis trials Research Report on Nephrolithiasis

Trials (filtered) newest first · largest first

All 4 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Study to Evaluate Lumasiran in Adults With Recurrent Calcium Oxalate Kidney Stone Disease and Elevated Urinary Oxalate Levels
Lumasiran, Placebo - Recurrent Calcium Oxalate Kidney Stone Disease, Elevated Urinary Oxalate Levels
Phase 2TerminatedAlnylam Pharmaceuticals22022-01-272024-05-22
Safety, Tolerability, and Pharmacodynamics of NOV-001 in Adult Subjects
NOV-001, NB1000S, NB2000P - Healthy Volunteers, Enteric Hyperoxaluria
Phase 1 / Phase 2TerminatedNovome Biotechnologies Inc1532021-06-022023-05-17
Efficacy and Safety of Using MPC-5971 in Subjects Undergoing Shock Wave Lithotripsy
placebo, MPC-5971 - Nephrolithiasis
Phase 2TerminatedMission Pharmacal1352010-04-012019-03-07
Dose-Dependent Effect of Thiazide in Dent's Disease Hypercalciuria
Hydrochlorothiazide - Dent's Disease, Nephrolithiasis
Phase 2 / Phase 3TerminatedAssistance Publique - Hôpitaux de Paris102003-07-012008-03-19

Narrower conditions

Kidney Calculi (3)  ·  Dent Disease (1)  ·  Hyperoxaluria (1)  ·  Urolithiasis (1)

Broader conditions

Female Urogenital Diseases (4)  ·  Female Urogenital Diseases and Pregnancy Complications (4)  ·  Kidney Diseases (4)  ·  Male Urogenital Diseases (4)  ·  Urogenital Diseases (4)  ·  Urologic Diseases (4)  ·  Calculi (3)  ·  Pathological Conditions, Anatomical (3)  ·  Pathological Conditions, Signs and Symptoms (3)  ·  Urinary Calculi (3)  ·  Urolithiasis (3)  ·  Congenital, Hereditary, and Neonatal Diseases and Abnormalities (1)  ·  Genetic Diseases, Inborn (1)  ·  Genetic Diseases, X-Linked (1)

Interventions

Hydrochlorothiazide (1)  ·  lumasiran (1)

Sponsors

Alnylam Pharmaceuticals (1)  ·  Assistance Publique - Hôpitaux de Paris (1)  ·  Mission Pharmacal (1)  ·  Novome Biotechnologies Inc (1)

Countries

United States (3)  ·  Belgium (1)  ·  Canada (1)  ·  France (1)  ·  Italy (1)  ·  Spain (1)  ·  Switzerland (1)  ·  United Kingdom (1)

Top investigators

Lachy McLean, MB ChB, PhD (1)

Results publications

PMID 18976849